Plain-English translation of NCT05665556 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This is a long-term observational study that tracks patients with connective tissue diseases — like lupus or scleroderma — who have developed a serious condition called pulmonary arterial hypertension, which is high blood pressure in the lungs. Researchers will follow you for five years, collecting information about your medical history, symptoms, and test results to understand how this condition progresses and which treatments work best for different patients.
Connective tissue diseases frequently lead to lung blood vessel damage and high blood pressure in the lungs, which can become life-threatening. While international studies have improved our understanding of this problem, Mexico needs its own research to learn about the condition in its patient population and to identify which patients are at highest risk and which treatments help them most.
You likely qualify if…
You likely don't qualify if…
You would enroll at a specialized center in Mexico and attend regular follow-up visits over five years. At these visits, your medical team will collect information about your symptoms, review your medical records, perform heart and lung tests (such as heart catheterization if needed), and monitor how you respond to any treatments you're already taking. The study is designed to be observational, meaning researchers are tracking your existing care rather than asking you to take a new medication.
AI-generated summary from trial data · Jun 5, 2026 · Not medical advice
Mexico
Sponsor
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Enrollment target
~170 participants
Started
December 2022
Primary completion
December 2027
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2023.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Jose Luis Hernandez Oropeza, PhD
Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.